Saller C F, Salama A I
Eur J Pharmacol. 1985 Apr 23;111(1):17-22. doi: 10.1016/0014-2999(85)90108-6.
S-Adenosyl-L-homocysteine (SAH, 2-100 microM) greatly inhibited protein carboxymethylation (PCM) in rat striatal synaptosomes, but did not alter the ability of apomorphine and other DA agonists to inhibit DA synthesis. SAH (10 microM) also did not significantly alter the ability of either 0.5 or 1.0 microM apomorphine to inhibit DA release from superfused rat striatal tissue slices, but it did antagonize the response to 5.0 microM apomorphine. The former two concentrations of apomorphine predominantly affected only DA release, whereas the latter concentration suppressed both DA and acetylcholine release. These findings are discussed with regard to the possible relationship between DA autoreceptor functioning and PCM activity.
S-腺苷-L-高半胱氨酸(SAH,2 - 100微摩尔)极大地抑制了大鼠纹状体突触体中的蛋白质羧甲基化(PCM),但并未改变阿扑吗啡和其他多巴胺激动剂抑制多巴胺合成的能力。SAH(10微摩尔)也未显著改变0.5或1.0微摩尔阿扑吗啡抑制超灌流大鼠纹状体组织切片中多巴胺释放的能力,但它确实拮抗了对5.0微摩尔阿扑吗啡的反应。前两个浓度的阿扑吗啡主要仅影响多巴胺释放,而后者浓度则抑制多巴胺和乙酰胆碱的释放。针对多巴胺自身受体功能与PCM活性之间可能的关系对这些发现进行了讨论。